Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.58 |
| ▸ | MMP1 | P03956 | 1/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.57 |
| ▸ | MMP12 | P39900 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 6/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.50 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28002724 | 0.95 | MMP2 (0.65) | MMP2MMP1MMP9MMP12TSHR | |
| SCHEMBL9496881 | 0.90 | ALDH1A1 (0.55) | MMP2MMP1MMP9MMP12TSHR | |
| SCHEMBL29020282 | 0.85 | RAB9A (0.49) | MMP2MMP1MMP9MMP12TSHR | |
| SCHEMBL428389 | 0.82 | RAB9A (0.53) | TSHRLMNAALDH1A1CYP1A2SMN1; SMN2 | |
| SCHEMBL16353007 | 0.81 | MMP2 (0.44) | MMP2MMP1MMP9MMP12TSHR | |
| Hydrochloric Acid SCHEMBL29099350 | 0.81 | RAB9A (0.51) | TSHRLMNAALDH1A1CYP1A2SMN1; SMN2 | |
| SCHEMBL1170832 | 0.81 | RAB9A (0.51) | MMP2TSHRL3MBTL1SMN1; SMN2RAB9A | |
| SCHEMBL28716266 | 0.81 | MMP2 (0.49) | MMP2MMP1MMP9MMP12TSHR | |
| SCHEMBL21104219 | 0.80 | RAB9A (0.43) | MMP2MMP1MMP9MMP12TSHR | |
| SCHEMBL21104427 | 0.80 | RAB9A (0.43) | MMP2MMP1MMP9MMP12TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119265552-A | Chemical nickel-plating palladium-gold solution | 生益电子股份有限公司 | 2025-01-07 | — | — | CN | claimed |
| WO-2023030423-A1 | ENVIRONMENTALLY FRIENDLY IMPREGNATION SYSTEM FOR FIBER SURFACE TREATMENT, AND PREPARATION METHOD AND IMPREGNATION TREATMENT METHOD THEREFOR | 北京化工大学 | 2023-03-09 | — | — | WO | claimed |
| CN-110143907-A | A kind of 9,10- dipyrryl anthracene fluorescent chemicals and its preparation method and application | 江西科技师范大学 | 2019-08-20 | — | — | CN | claimed |
| CN-119265552-A | Chemical nickel-plating palladium-gold solution | 生益电子股份有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-115093355-B | Preparation method of pyrrole ester compound | 河南农业大学 | 2024-06-04 | — | — | CN | disclosed |
| WO-2023030423-A1 | ENVIRONMENTALLY FRIENDLY IMPREGNATION SYSTEM FOR FIBER SURFACE TREATMENT, AND PREPARATION METHOD AND IMPREGNATION TREATMENT METHOD THEREFOR | 北京化工大学 | 2023-03-09 | — | — | WO | disclosed |
| CN-115093355-A | Preparation method of pyrrole ester compound | 河南农业大学 | 2022-09-23 | — | — | CN | disclosed |
| WO-2022194269-A1 | NOVEL EGFR DEGRADATION AGENT | 上海齐鲁制药研究中心有限公司 | 2022-09-22 | — | — | WO | disclosed |
| CN-110143907-A | A kind of 9,10- dipyrryl anthracene fluorescent chemicals and its preparation method and application | 江西科技师范大学 | 2019-08-20 | — | — | CN | disclosed |
| WO-2010082601-A1 | NOVEL 2,5-DISUBSTITUTED PYRROLE DERIVATIVE | 第一三共株式会社 (JP) | 2010-07-22 | — | — | WO | disclosed |
| US-20090325041-A1 | Lithium Secondary Battery | HITACHI, LTD. (JP) | 2009-12-31 | — | — | US | disclosed |
| WO-2005000806-A2 | LIGANDS FOR NICOTINIC ACETYLCHOLINE RECEPTORS, AND METHODS OF MAKING AND USING THEM | GEORGETOWN UNIVERSITY (US) | 2005-01-06 | — | — | WO | disclosed |
| WO-2004099373-A2 | BIOCOMPATIBLE RESISTS | UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (US) | 2004-11-18 | — | — | WO | disclosed |
| EP-1351684-A2 | COMPOUNDS AND METHODS FOR PROMOTING SMOKING CESSATION | Research Triangle Institute (US) | 2003-10-15 | — | — | EP | disclosed |
| WO-2002037927-A2 | COMPOUNDS AND METHODS FOR PROMOTING SMOKING CESSATION | RESEARCH TRIANGLE INSTITUTE (US) | 2002-05-16 | — | — | WO | disclosed |
| US-6384228-B2 | EPIBATIDINE; ANALGESICS; ANIMAL EXTRACTS | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |
| US-20020010339-A1 | METHOD FOR SYNTHESIS OF HALOPYRIDYL-ACYCLOPENTANE DERIVATIVE AND INTERMEDIATE THEREOF | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-0267794-B1 | PROCESS FOR PREPARING POLYOLEFINS | Nippon Petrochemicals Co., Ltd. (JP) | 1993-05-05 | — | — | EP | disclosed |
| EP-0267794-A2 | Process for preparing polyolefins | Nippon Petrochemicals Co., Ltd. (JP) | 1988-05-18 | — | — | EP | disclosed |
| US-4525555-A | TITANIUM COMPOUND SUPPORTED ON SOLID REACTION PRODUCT OF MAGNESIUM HALIDE, SILOXANES, ORGANIC COMPOUNDS | NIPPON OIL COMPANY, LIMITED (JP) | 1985-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010339-A1 | METHOD FOR SYNTHESIS OF HALOPYRIDYL-ACYCLOPENTANE DERIVATIVE AND INTERMEDIATE THEREOF | DHPS, ALAD, HAAO | MMP2 4472/4885MMP1 4288/4885MMP9 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.